Terms: = Kidney tumors AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Diagnosis
17 results:
1. Risk assessment for PFOA and kidney cancer based on a pooled analysis of two studies.
Steenland K; Hofmann JN; Silverman DT; Bartell SM
Environ Int; 2022 Sep; 167():107425. PubMed ID: 35905598
[TBL] [Abstract] [Full Text] [Related]
2. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
Chen L; Xiang Z; Chen X; Zhu X; Peng X
Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
[TBL] [Abstract] [Full Text] [Related]
3. Identification of potential key genes and key pathways related to clear cell renal cell carcinoma through bioinformatics analysis.
Zhai W; Lu H; Dong S; Fang J; Yu Z
Acta Biochim Biophys Sin (Shanghai); 2020 Aug; 52(8):853-863. PubMed ID: 32556097
[TBL] [Abstract] [Full Text] [Related]
4. [Differential diagnosis of Erythrocytosis - Background and Clinical Relevance].
Wille K; Sadjadian P; Griesshammer M
Dtsch Med Wochenschr; 2019 Jan; 144(2):128-135. PubMed ID: 30674061
[TBL] [Abstract] [Full Text] [Related]
5. Expression and Clinical Significance of Tissue Inhibitor of Metalloproteinases-1 (timp-1) and a Disintegrin and Metalloproteinase with Thrombospondin Type 1 Motif 1 (ADAMTS1) in Post-kidney-Transplant Bladder tumors.
Xue W; Zhang Z; Zeng S; Xu Y; Zhang Q; Wang W; Zhang Y; Zhang X; Hu X
Ann Transplant; 2017 Oct; 22():622-630. PubMed ID: 29038419
[TBL] [Abstract] [Full Text] [Related]
6. Cisplatin nephrotoxicity is not detected by urinary cell-cycle arrest biomarkers in lung cancer patients.
Toprak Z; Cebeci E; Helvaci SA; Toprak ID; Kutlu Y; Sakin A; Tukek T
Int Urol Nephrol; 2017 Jun; 49(6):1041-1047. PubMed ID: 28255639
[TBL] [Abstract] [Full Text] [Related]
7. Secondary Hypertension, Erythrocytosis, and Unilateral Renal Cystic Disease in a Submariner: A Case Report.
Forbes AS; Yeo FE
J Spec Oper Med; 2016; 16(4):1-5. PubMed ID: 28088811
[TBL] [Abstract] [Full Text] [Related]
8. Association of erythropoiesis-stimulating agents and the incidence risk of cancer diagnosis among chronic dialysis patients: a nested case-control study.
René É; Lazrak HH; Laurin LP; Elftouh N; Vallée M; Lafrance JP
Nephrol Dial Transplant; 2017 Jun; 32(6):1047-1052. PubMed ID: 27448671
[TBL] [Abstract] [Full Text] [Related]
9. [Erythropoietin: indications and measurement].
Klein E; Georges A; Brossaud J; Bosredon Kd; Bordenave L; Corcuff JB
Ann Biol Clin (Paris); 2009; 67(5):505-15. PubMed ID: 19789122
[TBL] [Abstract] [Full Text] [Related]
10. Can renal oncocytoma be differentiated from its renal mimics? The utility of anti-mitochondrial, caveolin 1, CD63 and cytokeratin 14 antibodies in the differential diagnosis.
Mete O; Kilicaslan I; Gulluoglu MG; Uysal V
Virchows Arch; 2005 Dec; 447(6):938-46. PubMed ID: 16133362
[TBL] [Abstract] [Full Text] [Related]
11. A man with a deltoid swelling and paraneoplastic erythrocytosis: case report.
Alimonti A; Di Cosimo S; Maccallini V; Ferretti G; Pavese I; Satta F; Di Palma M; Vecchione A
Anticancer Res; 2003; 23(6D):5181-4. PubMed ID: 14981986
[TBL] [Abstract] [Full Text] [Related]
12. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients.
Battagli C; Uzzo RG; Dulaimi E; Ibanez de Caceres I; Krassenstein R; Al-Saleem T; Greenberg RE; Cairns P
Cancer Res; 2003 Dec; 63(24):8695-9. PubMed ID: 14695183
[TBL] [Abstract] [Full Text] [Related]
13. Erythropoietin-producing renal cell carcinoma in chronic hemodialysis patients: a report of two cases.
Sakamoto S; Igarashi T; Osumi N; Imamoto T; Tobe T; Kamiya M; Ito H
Int J Urol; 2003 Jan; 10(1):49-51. PubMed ID: 12534927
[TBL] [Abstract] [Full Text] [Related]
14. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.
Liu J; Fanning CV
Cancer; 2001 Dec; 93(6):390-7. PubMed ID: 11748579
[TBL] [Abstract] [Full Text] [Related]
15. Erythropoietin immunolocalization in renal cell carcinoma.
Clark D; Kersting R; Rojiani AM
Mod Pathol; 1998 Jan; 11(1):24-8. PubMed ID: 9556419
[TBL] [Abstract] [Full Text] [Related]
16. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract] [Full Text] [Related]
17. Sarcomatoid renal cell carcinoma. A treatable entity.
Sella A; Logothetis CJ; Ro JY; Swanson DA; Samuels ML
Cancer; 1987 Sep; 60(6):1313-8. PubMed ID: 2441841
[TBL] [Abstract] [Full Text] [Related]
